Abstract
Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non-Hodgkin lymphoma affecting the brain, particularly periventricular areas, leptomeninges, spinal cord, and/or eyes. Immunocompromised patients are at greater risk than immunocompetent individuals especially patients with AIDS. Diagnosis is made through stereotactic needle biopsy. Cerebrospinal fluid analysis and victrectomy or choroidal/retinal biopsy may be sufficient to render the diagnosis. CNS staging requires evaluating the extent of disease and systemic disease must be ruled out prior to initiating treatment. Chemotherapy using a high dose HD-MTX based regimen is the first line of treatment.
Original language | English (US) |
---|---|
Title of host publication | Oncology |
Publisher | wiley |
Pages | 364-375 |
Number of pages | 12 |
ISBN (Electronic) | 9781119189596 |
ISBN (Print) | 9781119189558 |
DOIs | |
State | Published - Aug 30 2019 |
Externally published | Yes |
Keywords
- AIDS
- Diffuse large b-cell
- Leptomeningeal
- Lymphoma
- Methotrexate
- Ocular
- PCNSL
ASJC Scopus subject areas
- Medicine(all)